Aqr Capital Management LLC Hutchmed (China) LTD Transaction History

Aqr Capital Management LLC

  • $64.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$27.79 - $34.49 $1.36 Million - $1.68 Million
-48,809 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$28.87 - $41.13 $975,921 - $1.39 Million
33,804 Added 225.28%
48,809 $1.44 Million
Q4 2017

Feb 14, 2018
BUY
$27.41 - $39.42 $80,886 - $116,328
2,951 Added 24.48%
15,005 $591,000
Q3 2017

Nov 14, 2017
BUY
$22.15 - $27.5 $266,996 - $331,485
12,054
12,054 $329,000

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email